SONOVA (OTCMKTS:SONVY) Downgraded by Zacks Research to “Hold”

SONOVA (OTCMKTS:SONVY) was downgraded by Zacks Research from a “strong-buy” rating to a “hold” rating in a note issued to investors on Wednesday,Zacks.com reports.

Several other analysts have also issued reports on SONVY. BNP Paribas began coverage on SONOVA in a research note on Monday. They issued an “underperform” rating on the stock. Sanford C. Bernstein upgraded SONOVA from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 18th. Finally, Rothschild Redb upgraded SONOVA from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce”.

SONOVA Stock Down 0.9%

Shares of SONVY opened at $57.28 on Wednesday. The stock’s fifty day moving average price is $57.13 and its two-hundred day moving average price is $58.86. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.96 and a current ratio of 1.27. SONOVA has a 1 year low of $52.83 and a 1 year high of $77.56.

SONOVA Company Profile

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.